News
April 2003 Issue
In the News: 04/03
New Arthritis Drug Breaks The Marketing Mold—It’s Free Abbot Laboratories, makers of the rheumatoid arthritis drug Humira, announced in January that it will provide its recently approved drug free to Medicare patients without drug coverage—at least until the government agrees to pay for it. The move, according to an article by reporter Bruce Japsen in the Chicago Tribune, “is part altruism and part marketing because the company’s drug is competing with a rival—Remicade—that has Medicare coverage.
To continue reading this entire article you must be a paid subscriber.
Subscribe to Arthritis Advisor
Arthritis Advisor is the first magazine published by one one of the world's leading orthopaedic hospitals specifically for people with arthritis.
Already subscribe but haven't registered for all the benefits of the website? Click here.
Subscriber Log In
Forgot your password? Click Here.